Screener
Cumberland Pharmaceuticals CPIX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -30.8%-13.8pp | -30.4%-22.5pp | -15.2%+1.8pp | -18.3%+11.0pp | -17%+12.0pp | |
| Net margin | -34.9%-25.6pp | -23.5%-15.5pp | -8.3%+8.8pp | -10.8%+18.8pp | -9.3%+18.2pp | |
| Returns | ||||||
| Return on equity | -48.1%-37.3pp | -29.4%-17.7pp | -11.9%+12.8pp | -13.1%+22.7pp | -10.8%+21.9pp | |
| Return on invested capital | -54.6%-20.5pp | -56%-36.4pp | -30.7%+9.3pp | -39.4%+20.6pp | -34.1%+21.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.4×-0.1× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1×-0.3× | 1×-0.3× | 1×-0.1× | 1.2×+0.1× | 1.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×+0.1× | 0.2×0.0× | 0.2×-0.3× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $1.16-37.8% | $1.45-23.0% | $1.67+3.0% | $1.75-1.0% | $1.87+0.2% | |
| Valuation | ||||||
| Market capitalization | $134.4M+164% | $48.61M-17.7% | $59.53M+78.9% | $46.68M+158% | $49.37M+129% | |
| Price / sales | 4.3×+2.7× | 1.5×+0.1× | 1.7×+0.9× | 1.5×+1.0× | 1.6×+1.0× | |
| Price / book | 7.7×+5.9× | 2.2×+0.2× | 2.4×+0.9× | 1.8×+1.1× | 1.8×+0.9× |
FAQ
- What are Cumberland Pharmaceuticals's profit margins?
- Cumberland Pharmaceuticals (CPIX) runs a 77.2% gross margin and a -30.8% operating margin, with a -34.9% net margin.
- Where do Cumberland Pharmaceuticals's ratios come from?
- Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
